Natrecor in Pulmonary Hypertension
Stopped early · Phase 4
Conditions studied: Pulmonary Hypertension, Cancer, Lung Disease, Cardiothoracic Surgery
In brief
The goal of this clinical research study is to learn if the drug nesiritide (Natrecor) is effective in lowering the pressure in your lungs. The primary objective of this study is to establish that Nesiritide (Natrecor) is effective in reducing pulmonary hypertension (PHTN) acutely as measured by a 20% reduction in the mean pulmonary arterial (PA) pressure. The secondary objectives will include: improvement in pulmonary vascular resistance (PVR), patient symptoms, exercise tolerance, frequency of toxicity, and surgeon's willingness to proceed with operation.
Key facts
- Study ID
- NCT00075179
- Run by
- M.D. Anderson Cancer Center
- People needed
- 15
- Starts
- 2003-12-31
- Expected to finish
- 2006-03-28
- Last updated by the study team
- 2018-11-07
Who can join
Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Ages 18 to 85 years old.
- Evidence of underlying lung disease by history and physical and/or chest x-ray and/or pulmonary function testing (PFT's).
- PHTN documented by Doppler Echocardiography ( Done with in last 30 days)
- Must be able to give an informed consent.
You may not qualify if…
- Patients with clinically significant hypotension (defined as a systolic blood pressure (SBP) <90).
- Active infection or sepsis as defined by fever and need for IV antibiotics.
- Creatinine greater than 3.0 mg/dl
- Significant valvular disease as a cause for the PHTN.
- Severe Thrombocytopenia (as defined by platelets less than 20,000 or INR > 1.6.
- Left Ventricle Ejection Fraction (LVEF) <40% (must be done with in the last 30 days prior to signing consent).
- Hypersensitivity to nesiritide or any of it's components.
Where it is running
- MD Anderson Cancer Center — Houston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.